MBIO

Mustang Bio (MBIO)

Mustang Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MBIO

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/13	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MBIO	Mustang Bio Inc
2024/06/07	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/06/05	09:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MBIO	Mustang Bio Inc
2024/06/05	09:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MBIO	Mustang Bio Inc
2024/06/01	06:09	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:MBIO	Mustang Bio Inc
2024/05/22	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/05/13	19:01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:MBIO	Mustang Bio Inc
2024/05/03	05:01	GlobeNewswire Inc.	Mustang Bio Announces Closing of $4 Million Public Offering	NASDAQ:MBIO	Mustang Bio Inc
2024/04/30	09:00	GlobeNewswire Inc.	Mustang Bio Announces Pricing of $4 Million Public Offering	NASDAQ:MBIO	Mustang Bio Inc
2024/03/28	22:00	GlobeNewswire Inc.	Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases	NASDAQ:MBIO	Mustang Bio Inc
2024/03/12	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/03/12	05:05	GlobeNewswire Inc.	Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights	NASDAQ:MBIO	Mustang Bio Inc
2024/03/12	05:02	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:MBIO	Mustang Bio Inc
2024/03/07	21:30	GlobeNewswire Inc.	Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma	NASDAQ:MBIO	Mustang Bio Inc
2024/02/15	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/01/26	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2024/01/11	22:30	GlobeNewswire Inc.	Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference	NASDAQ:MBIO	Mustang Bio Inc
2024/01/05	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2023/12/20	06:06	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MBIO	Mustang Bio Inc
2023/12/12	11:52	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:MBIO	Mustang Bio Inc
2023/12/11	22:37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2023/12/11	22:30	GlobeNewswire Inc.	Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting	NASDAQ:MBIO	Mustang Bio Inc
2023/11/15	06:44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2023/11/15	06:05	GlobeNewswire Inc.	Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights	NASDAQ:MBIO	Mustang Bio Inc
2023/11/04	04:22	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:MBIO	Mustang Bio Inc
2023/11/03	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2023/11/02	22:28	GlobeNewswire Inc.	Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation at 65th American Society of Hematology (ASH) Annual Meeting	NASDAQ:MBIO	Mustang Bio Inc
2023/10/31	03:57	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBIO	Mustang Bio Inc
2023/10/31	03:15	GlobeNewswire Inc.	Mustang Bio Announces Closing of $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:MBIO	Mustang Bio Inc
2023/10/30	23:30	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:MBIO	Mustang Bio Inc